Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 25.01.2022 at 9:00 AM CET
Settings

Settings

Goto Application

1. WO2022008702 - METHODS FOR TREATING CARDIOVASCULAR DISEASE

Publication Number WO/2022/008702
Publication Date 13.01.2022
International Application No. PCT/EP2021/069098
International Filing Date 09.07.2021
IPC
A61P 9/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
A61P 9/10 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
10for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
C07K 16/24 2006.1
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
16Immunoglobulins, e.g. monoclonal or polyclonal antibodies
18against material from animals or humans
24against cytokines, lymphokines or interferons
A61K 39/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
Applicants
  • NOVO NORDISK A/S [DK]/[DK]
Inventors
  • DEVALARAJA, Madhav N
  • DAVIDSON, Michael H
  • KAKKAR, Rahul
Agents
  • J A KEMP LLP
Priority Data
63/050,44110.07.2020US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) METHODS FOR TREATING CARDIOVASCULAR DISEASE
(FR) MÉTHODES DE TRAITEMENT D'UNE MALADIE CARDIOVASCULAIRE
Abstract
(EN) The disclosure provides methods of treating cardivascular disease, including pateints with atherosclerotic cardiovascular disease and/or chronic kidney disease.. The method comprises administering a therapeutically effective amount of ziltivekimab.
(FR) L'invention concerne des méthodes de traitement d'une maladie cardiovasculaire, y compris des patients atteints d'une maladie cardiovasculaire athéroscléreuse et/ou d'une maladie rénale chronique. La méthode comprend l'administration d'une quantité thérapeutiquement efficace de ziltivékimab.
Latest bibliographic data on file with the International Bureau